Clinical Trials

Glioblastoma Multiforme (GBM)

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 3 of 3 Clinical Trials Related to Glioblastoma Multiforme (GBM)

Clinical Research Trial

MSK 20 -091

A Phase II Study of Pembrolizumab, Olaparib, and Temozolomide in Patients with Glioma

Doctor(s) Running This Study
Tara Morrison, MD
Clinical Research Trial

NRG-BN011

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

MSK 18-400 Glioblastoma

A Phase II Trial of the PD-1 Antibody Nivolumab in Combination with Hypofractionated Re-irradiation and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Doctor(s) Running This Study
Tara Morrison, MD